Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
28 hedge funds and large institutions have $26.9M invested in Global Cord Blood Corporation in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 7 closing their positions.
15% more capital invested
Capital invested by funds: $23.5M → $26.9M (+$3.44M)
13% less funds holding
Funds holding: 32 → 28 (-4)
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
67% less call options, than puts
Call options by funds: $1K | Put options by funds: $3K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$707K |
| 2 |
Renaissance Technologies
New York
|
+$626K |
| 3 |
MWA
Marshall Wace Asia
Central,
Hong Kong
|
+$162K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$138K |
| 5 |
Man Group
London,
United Kingdom
|
+$60.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
-$602K |
| 2 |
Millennium Management
New York
|
-$217K |
| 3 |
Two Sigma Advisers
New York
|
-$144K |
| 4 |
Morgan Stanley
New York
|
-$121K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$112K |
CO Hedge Fund Activity: Q3 2020 in Review
28 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q3 2020, worth a combined $26.9M — up 15% from $23.5M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of CO and 3 opened new positions — a net loss of 4 holders — while 9 trimmed existing stakes and 5 added.
The largest buyer was Arrowstreet Capital, adding an estimated $707K. The largest seller was Norges Bank, exiting entirely with an estimated $602K sold.
- 28 institutional investors held Global Cord Blood Corporation (CO) as of Q3 2020, down from 32 in Q2 2020.
- Funds reported $26.9M of Global Cord Blood Corporation stock for Q3 2020, up 15% quarter-over-quarter.
- 3 funds opened new Global Cord Blood Corporation positions in Q3 2020 and 7 closed out, a net change of -4 holders.
- The largest Global Cord Blood Corporation buyer in Q3 2020 was Arrowstreet Capital, an estimated $707K added.
- The largest Global Cord Blood Corporation seller in Q3 2020 was Norges Bank, an estimated $602K sold.
Based on aggregated 13F filings for Q3 2020.